Flurona is an informal term for being infected with influenza and COVID-19 at the same time. It is not a new hybrid virus or a unique disease. It simply describes a co-infection where both viruses are active in your body simultaneously, producing overlapping symptoms that can be difficult to tell apart without testing.
The term gained widespread attention in late 2021 and early 2022, during the Omicron surge, when case reports of patients testing positive for both viruses began making headlines. While the name sounds alarming, it’s worth understanding what it actually means, how it differs from a single infection, and what you can do about it.
Why the Name Is Misleading
The word “flurona” blends “flu” and “corona,” which makes it sound like a single merged pathogen. Some researchers have pointed out that this terminology is misleading because it implies a recombinant virus, one that contains genetic material from both influenza and SARS-CoV-2. That’s not what’s happening. The two viruses remain entirely separate. They just happen to infect the same person at the same time.
Some scientists have proposed the alternative term “flucovid” to make the distinction clearer: a disease state that combines symptoms of both flu and COVID-19, rather than a new pathogen. That term hasn’t caught on publicly, but the point stands. Flurona is a media-friendly label for a straightforward medical situation: dual infection.
What Co-Infection Feels Like
Because influenza and COVID-19 share many symptoms, a co-infection often looks a lot like a bad case of either one. Fever, cough, fatigue, headache, and shortness of breath are common to both viruses. COVID-19 may add loss of taste or smell, while influenza tends to hit harder with body aches and chills. When both viruses are present, you can experience the full range of symptoms from each.
The tricky part is that there’s no single symptom that reliably signals co-infection. You can’t tell the difference between flurona and a severe case of flu or COVID-19 based on how you feel alone. This is why testing matters, especially during winter respiratory virus season when both viruses circulate widely.
Is It More Dangerous Than a Single Infection?
Animal studies have shown that simultaneous or back-to-back infection with influenza and SARS-CoV-2 leads to more severe outcomes than either virus alone. Researchers observed greater weight loss, more lung inflammation and damage, and higher levels of inflammatory signaling molecules in co-infected animals compared to those with a single infection.
In humans, the picture is less clear-cut. Case reports have raised concerns about increased severity, but large-scale data is limited. One challenge is that co-infection rates are relatively low, partly because the public health measures used during the pandemic (masking, distancing) suppressed influenza transmission in 2020 and 2021. As both viruses now circulate more freely, researchers are still working to determine whether co-infection consistently raises the risk of hospitalization or death beyond what each virus poses individually. The biological plausibility is there, given what the animal data shows, but the real-world human risk depends heavily on factors like vaccination status, age, and underlying health conditions.
How Doctors Detect It
A standard COVID-19 rapid test or a basic flu test will only detect one virus. To identify co-infection, labs use a multiplex test that checks for multiple pathogens in a single sample. The CDC developed one called the Flu SC2 Multiplex Assay, which can simultaneously detect and distinguish between influenza A, influenza B, and SARS-CoV-2 from a single nasal or throat swab. It’s a highly accurate molecular test designed for use during the acute phase of infection, when viral levels are high enough to detect.
If you’re feeling significantly worse than expected with respiratory symptoms, or your symptoms don’t follow the typical pattern of one virus, asking your provider to test for both can help guide treatment decisions.
How Co-Infection Is Treated
Because flurona involves two separate viruses, treatment targets each one individually. Influenza has its own class of antiviral medications, and COVID-19 has its own. The challenge is choosing the right combination and dosing.
Lab research has found that using antivirals for both viruses together works better than treating just one. In cell-based experiments, combining a COVID-19 antiviral with an influenza antiviral effectively suppressed both viruses, including the Omicron BA.5 variant. The combination also allowed researchers to use lower doses of each drug than would be needed if either were used alone. Interestingly, the same research found that influenza can actually interfere with SARS-CoV-2’s ability to replicate, reducing COVID-19 viral levels during co-infection. But even with that natural interference, antiviral treatment still provided meaningful benefit.
In practice, your treatment will depend on how severe your symptoms are, how soon you’re diagnosed, and your risk factors. Antivirals for both flu and COVID-19 work best when started early, ideally within the first day or two of symptoms.
Vaccination Prevents Both at Once
The most effective way to reduce your risk of co-infection is to get vaccinated against both viruses. You can receive a flu vaccine and a COVID-19 vaccine during the same visit. Studies reviewed by the CDC support the safety of this approach. People who received both shots at once were slightly more likely to report mild reactions like fatigue, headache, and muscle aches compared to those who got only the COVID-19 vaccine, but those side effects were mostly mild and resolved quickly.
There’s no required waiting period between the two vaccines. If you prefer to space them out, that’s fine too. The shots just need to be given at least one inch apart on your body. You can also add an RSV vaccine at the same visit if you’re eligible for one.
Getting vaccinated against both flu and COVID-19 doesn’t guarantee you won’t catch either virus, but it substantially lowers your chances of severe illness from each. That, in turn, makes a co-infection scenario far less likely to land you in the hospital.